From: Advances of nano drug delivery system for the theranostics of ischemic stroke
Molecular imaging methods | Shortcomings before enhancement | Improved methods for applying nanocarriers | Results | Refs. |
---|---|---|---|---|
Magnetic resonance imaging (MRI) | Low signal intensity and sensitivity | MNPs conjugated with antibodies | Become both a MRI contrast enhancement agent and a selective biological recognizer of target molecules | [64] |
Lipid-encapsulated perflurocarbon NPs | Detect the microthrombin that form on the intimal surfaces of unstable atherosclerotic plaque sensitively and specifically | [67] | ||
An integrin αvβ3-specific Fe3O4 nanoprobe modified with RGD tripeptide | Visualize the collaterals during acute IS | [68] | ||
PEGylated ultrasma paramagnetic Gd2O3 NPs | Label and track cells in brain | [69] | ||
Positron emission spectroscopy (PET) | Always used together with MRI and CT | NPs consisted of a SPIO core labelled with 64Cu and coated with PEGylated phospholipids | Show high initial blood retention with moderate liver uptake | [72] |
18F-modified polyglucose NPs | Exhibit high affinity for macrophages | [73] | ||
Computed tomography (CT) | Not sensitive within the differentiation of penumbral and infarct core region | Au NPs grown in the PEGylated dendrimer | Achieve a blood pool imaging better than a commercial iodine agent | [77] |
PEGylated BaHoF5 nanoprobes | Much lower dosage required, main metabolism through liver and better imaging efficiency at different voltages | [78] | ||
Exosome-labeled with glucose coated gold nanoparticles | Exhibit better accumulation of particles in the ischemic region | [81] | ||
Ultrasonography | Difficult to penetrate the cranium | PDI NPs conjugated with cRGD | Monitor the obstructive degree of thrombus and the thrombolysis effect in time | [84] |